Storage conditions：Short-term storage at 2~8℃, long-term storage at -20 ~ -80℃

Introduction/Overview

Cytidine, CAS number 65-46-3, is an important pyrimidine nucleoside compound. As one of the basic units of RNA, it is widely found in living organisms. Cytosine nucleoside is not only an essential precursor for RNA synthesis but also plays an important role in cellular metabolism, signal transduction, and regulation of nervous system function. In recent years, cytosine nucleosides have gradually become a hot topic in neuropharmacology and metabolic disease research due to their potential roles in regulating glial glutamate circulation, brain phospholipid metabolism, catecholamine synthesis, and mitochondrial function maintenance. In addition, the prospects for cytosine nucleoside in the antiviral field have attracted widespread attention, with targets covering various viral proteins and host receptors, demonstrating promising antiviral potential.

This paper aims to systematically review the chemical structure and physicochemical properties of cytosine nucleosides, plant origins and extraction methods, pharmacological activity and mechanism of action, druggability evaluation and pharmacokinetic characteristics, and to explore their clinical application prospects and development trends, providing a theoretical foundation and reference for related research and drug development.

Chemical structure and physicochemical properties

The chemical structure of cytosine nucleoside consists of the pyrimidine base cytosine connected to the ribose molecule via β-N1-glycosidic bonds, with a molecular formula of C9H13N3O5 and a molecular weight of 243.2190. Its structural characteristics determine that cytosine nucleoside has high polarity and hydrophilicity, with a LogP value of -2.1503, indicating strong water solubility (22.8682 mg/mL), which is beneficial for its dissolution and transport in organisms. Its topological pole surface area (TPSA) is 130.83 Ų, indicating that cytosine nucleoside has a strong polar group, facilitating binding to enzymes and receptors.

The cytosine nucleoside is structurally stable and does not exhibit hERG channel inhibitory activity; the Ames test result is 0.9, indicating a low genotoxicity risk. Additionally, cytosine nucleoside has a high blood-brain barrier penetration ability, a property that lays the foundation for its application in the treatment of central nervous system diseases.

Plant Origins and Extraction Methods

As a nucleoside compound, cytosine nucleoside is widely present in various organisms, including plants, microorganisms, and animal tissues. Although cytosine nucleosides are mainly produced within cells through biosynthetic pathways, some plants also contain certain amounts of cytosine nucleosides, especially in plant tissues rich in nucleic acids.

Traditional cytosine nucleoside extraction methods mainly rely on hydrolysis and separation of nucleic acids, including acidic or enzymatic hydrolysis of RNA, followed by purification through ion exchange chromatography, reversed-phase high-performance liquid chromatography (RP-HPLC), and other techniques. In recent years, the introduction of ultrasound-assisted extraction and membrane separation technology has improved the extraction efficiency and purity of cytosine nucleosides. In addition, the technology for genetically engineered microbial fermentation to produce cytosine nucleosides is gradually maturing and has become an important approach for industrial preparation.

Pharmacological activity research

The pharmacological activities of cytosine nucleoside cover neuroprotection, antiviral, and metabolic regulation.

Neuroprotective effects

The mechanism of cytosine nucleoside action in the nervous system mainly regulates glial cell circulation to glutamic acid, reduces excitatory neurotoxicity, and protects neurons from damage caused by overexcitement. Additionally, cytosine nucleosides participate in brain phospholipid metabolism, promote nerve membrane repair and regeneration, and improve nerve conduction function. Its regulatory effect on catecholamine synthesis helps maintain neurotransmitter balance and improves cognitive and emotional states. Cytosine nucleoside also regulates mitochondrial function, enhances cellular energy metabolism, reduces oxidative stress, and demonstrates its potential to combat neurodegenerative diseases.

Antiviral activity

Citine nucleoside demonstrates multi-target effects in antiviral research, capable of interfering with viral replication and infection processes. Its targets include myeloperoxidase (MPO), herpesvirus proteins UL42, UL54, ICP27, thymidine kinase (TK), membrane glycoprotein gD, as well as HIV-related targets such as CCR5, CXCR4, HIV1 protease (HIV1-PR), and integrase (INT). These targets involve key steps such as viral gene replication, protein synthesis, and host cell invasion. Cytosine nucleosides regulate these targets to inhibit viral replication and reduce pathological damage caused by viral infections.

Other pharmacological effects

Cytosine nucleoside has also been found to participate in regulating immune responses and has certain anti-inflammatory effects. Moreover, its regulatory role in cellular metabolism gives it potential value in research on metabolic syndrome and related diseases.

Mechanism of action and molecular targets

The mechanism of action of cytosine nucleoside is complex, involving multiple signaling pathways and molecular targets.

Mechanisms in the nervous system

Cytosine nucleoside regulates the glutamate transporter protein in glial cells, promotes glutamate uptake and metabolism, reduces glutamate accumulation in the synaptic cleft, and prevents excitotoxicity. Additionally, cytosine nucleoside promotes brain phospholipid synthesis, enhancing the stability and functional integrity of nerve cell membranes. Its promoting effect on catecholamine synthesis may be achieved by regulating tyrosine hydroxylase activity, thereby affecting levels of neurotransmitters such as dopamine and norepinephrine. Citine nucleoside also regulates the activity of the mitochondrial respiratory chain complex, maintains cellular energy metabolism, reduces reactive oxygen species (ROS) production, and prevents apoptosis.

Antiviral mechanism

Cytosine nucleosides inhibit viral DNA or RNA synthesis by binding to enzymes and proteins related to viral replication. Specifically, cytosine nucleoside interferes with the functions of herpesvirus UL42 and UL54 proteins, blocking viral DNA polymerase activity and inhibiting viral replication. For HIV virus, cytosine nucleoside blocks CCR5 and CXCR4 receptors, preventing viral invasion of host cells, while inhibiting HIV protease and integrase activity, interfering with multiple stages of the viral life cycle. In addition, cytosine nucleoside regulates the host's immune system, helping to enhance the body's antiviral ability.

Druggability evaluation and pharmacokinetics

The physicochemical properties of cytosine nucleosides show good water solubility and low lipid solubility, which is beneficial for oral absorption and internal distribution. Its LogP value was -2.1503, indicating cytosine nucleoside is hydrophilic, which may limit its passive diffusion through lipid membranes, but high blood-brain barrier permeability suggests it may enter the central nervous system via specific transport mechanisms.

Cytosine nucleoside does not exhibit hERG channel inhibitory activity, reducing the risk of cardiotoxicity. The Ames test result was 0.9, indicating a low genotoxicity risk and good safety. Pharmacokinetic studies show that cytosine nucleosides have a relatively fast metabolic rate in the body, mainly through nucleosidase hydrolysis, and their metabolites participate in nucleic acid synthesis and energy metabolism.

However, the oral bioavailability of cytosine nucleoside is limited and may require optimization of drug formulations or changes in administration routes to enhance clinical effectiveness. Its high blood-brain barrier permeability offers advantages in treating neurological diseases, but further research is needed on its metabolism and duration of action in the brain.

Prospects and outlooks for clinical applications

The potential of cytosine nucleoside in neuroprotection and antiviral fields offers broad clinical application prospects. In neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, and brain injury repair, cytosine nucleoside is expected to become a new therapeutic strategy by regulating glial cell function and neurotransmitter balance. Additionally, cytosine nucleoside demonstrates multi-target synergistic inhibitory effects in antiviral therapy, especially targeting herpesvirus and HIV infection. In the future, it can be used in combination with existing antiviral drugs to enhance efficacy and reduce resistance risk.

Future research should focus on optimizing cytosine nucleoside drug formulations, developing targeted delivery systems, and validating clinical trials to further clarify its safety and efficacy. At the same time, in-depth analysis of cytosine nucleoside mechanisms in cellular metabolism and signal transduction will help expand its applications in immune regulation and metabolic disease treatment.

Conclusion

As a natural pyrimidine nucleoside compound, cytosine nucleoside has become a key focus in natural product pharmacology research due to its important biological functions in RNA synthesis, neuroprotection, and antiviral functions. Its excellent physicochemical properties and safety provide favorable conditions for drug development. In the future, as molecular mechanisms are further revealed and pharmaceutical formulation technology advances, cytosine nucleoside is expected to play a greater role in treating neurological diseases and viral infections, becoming an important representative of the new generation of natural product drugs.